Montelukast for the high impact of asthma exacerbations in Venezuela: a practical and valid approach for Latin America

Juan Carlos Ivancevich Tuesday, 23 September 2014 16:11
Open Access
Original research

Arnaldo Capriles Hulett1*Maria Gonzalez Yibirin2Amaris Garcia3 and Dollys Hurtado4

‘They said it was bronchiolitis; is it going to turn into asthma doctor?’

Juan Carlos Ivancevich Tuesday, 26 August 2014 15:22
Cover image for Vol. 19 Issue 6
 
 
Dimos Gidaris, Don Urquhart and Michael B. Anthracopoulos

Gaining the Upper Hand on Pulmonary Drug Delivery

Juan Carlos Ivancevich Tuesday, 19 August 2014 13:52

 

Journal of Pharmacovigilance


Open Access
 
ISSN: 2329-6887

J Pharmacovigil. 2014 Mar 1;2(1):118.

Tyrrell J, Tarran R.

Beta-2 Adrenergic Receptor (ADRB2) Gene Polymorphisms and the Risk of Asthma: A Meta-Analysis of Case-Control Studies

Juan Carlos Ivancevich Wednesday, 20 August 2014 15:50
PLoS One. 2014; 9(8): e104488.
Published online Aug 11, 2014. doi:  10.1371/journal.pone.0104488
PMCID: PMC4128804
 

Operational definitions of asthma in recent epidemiological studies are inconsistent

Juan Carlos Ivancevich Saturday, 09 August 2014 18:37
 
Open Access
 
Review

Ana Sá-SousaTiago JacintoLuís Filipe AzevedoMário Morais-AlmeidaCarlos Robalo-CordeiroAntónio Bugalho-AlmeidaJean Bousquet and João Almeida Fonseca

Interasma on Twitter

Interasma RT @worldallergy: Top story: FDA Approves Asthma Indication for Dupixent® (dupilumab) | Markets Insider https://t.co/ZrphQSaJqf, see more h…
6hreplyretweetfavorite
Interasma RT @EAACI_HQ: #Probiotics: a novel treatment option for chronic #airwaydiseases? Read this review! @PETERHELLINGS2 #Allergy_journal https:…
6hreplyretweetfavorite
Interasma RT @worldallergy: WAO Tweeted Times https://t.co/1tA4uy3LDq - top stories by @wheezemd, @GoAllergy
6hreplyretweetfavorite
Interasma RT @Aller_MD: My Tweeted Times https://t.co/36WLWcQjoy - top stories by @ad_rogers, @EAACI_JM
6hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA